Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Pulmatrix (PULM) EBIT (2016 - 2025)

Pulmatrix (PULM) has disclosed EBIT for 13 consecutive years, with -$908000.0 as the latest value for Q4 2025.

  • Quarterly EBIT rose 53.48% to -$908000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.2 million through Dec 2025, up 47.06% year-over-year, with the annual reading at -$5.2 million for FY2025, 47.06% up from the prior year.
  • EBIT hit -$908000.0 in Q4 2025 for Pulmatrix, down from -$866000.0 in the prior quarter.
  • In the past five years, EBIT ranged from a high of $747000.0 in Q1 2024 to a low of -$8.2 million in Q3 2021.
  • Historically, EBIT has averaged -$3.4 million across 5 years, with a median of -$4.0 million in 2023.
  • Biggest five-year swings in EBIT: plummeted 541.35% in 2021 and later skyrocketed 116.29% in 2024.
  • Year by year, EBIT stood at -$4.0 million in 2021, then decreased by 6.98% to -$4.3 million in 2022, then soared by 48.55% to -$2.2 million in 2023, then grew by 12.27% to -$2.0 million in 2024, then skyrocketed by 53.48% to -$908000.0 in 2025.
  • Business Quant data shows EBIT for PULM at -$908000.0 in Q4 2025, -$866000.0 in Q3 2025, and -$1.5 million in Q2 2025.